ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Brachyury in Prostate Cancer Progression and Prognosis (Clinical Cancer Research) Sunday September 14th 2014


100) BAP1 and KDM6A Bladder Cancer Mutations (Clinical Cancer Research) Sunday September 14th 2014


101) Molecular Features of Prostate Cancer in African Americans (Clinical Cancer Research) Sunday September 14th 2014


102) Smoking and Genomic Alterations in Lung Adenocarcinoma (Clinical Cancer Research) Sunday September 14th 2014


103) SPINK1 and Prostate Cancer (Clinical Cancer Research) Sunday September 14th 2014


104) Novel MSH6 Mutations and Temozolomide Resistance in Glioma (Clinical Cancer Research) Sunday September 14th 2014


105) Demethylating Drugs and Cancer Pain (Clinical Cancer Research) Sunday September 14th 2014


106) Mitochondrial Topoisomerase I Determines Doxorubicin Cardiotoxicity (Clinical Cancer Research) Sunday September 14th 2014


107) On-Target Apoptosis-Mediated Death by FK866 in CLL Cells (Clinical Cancer Research) Sunday September 14th 2014


108) BEZ235/Panobinostat Exhibits Potent Anti-NHL Activity (Clinical Cancer Research) Sunday September 14th 2014


109) Neoadjuvant Chemotherapy Reveals Specific Biomarkers (Clinical Cancer Research) Sunday September 14th 2014


110) Personalized Medicine in a Phase I Clinical Trials Program (Clinical Cancer Research) Sunday September 14th 2014


111) Functional Assay for PARP Inhibitor Treatment (Clinical Cancer Research) Sunday September 14th 2014


112) Imaging Reversal of MET-Mediated Resistance in NSCLC (Clinical Cancer Research) Sunday September 14th 2014


113) Clinical Significance of EpCAM mRNA-Positive CTCs in HCC (Clinical Cancer Research) Sunday September 14th 2014


114) miRNAs Predict Chemosensitivity in Lung Adenocarcinoma (Clinical Cancer Research) Sunday September 14th 2014


115) Phase I Study of RGB-286638 (Clinical Cancer Research) Sunday September 14th 2014


116) Role of Age on DLTs in Phase I Dose-Escalation Trials (Clinical Cancer Research) Sunday September 14th 2014


117) An Alternative Design for Cancer Vaccine Trials (Clinical Cancer Research) Sunday September 14th 2014


118) Phase I Study of MEDI-573 in Advanced Solid Tumors (Clinical Cancer Research) Sunday September 14th 2014


119) Targeting RAC-PAK Signaling in RAS-Driven Cancers (Clinical Cancer Research) Sunday September 14th 2014


120) Doxorubicin Targets Mitochondrial DNA (Clinical Cancer Research) Sunday September 14th 2014


121) SPINK1 and ERG in Prostate Cancer (Clinical Cancer Research) Sunday September 14th 2014


122) GSK-3{beta}-Regulated N-Acetyltransferase 10 in Colorectal Carcinoma Invasion (Clinical Cancer Research) Tuesday September 2nd 2014


123) miR216a Suppresses NSCLC Growth, Metastasis, and Chemoresistance (Clinical Cancer Research) Tuesday September 2nd 2014


124) TMEFF2 and Tumorigenesis Signatures in Gastric Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


125) TMEM16A, a Switch between Tumor Growth and Metastasis (Clinical Cancer Research) Tuesday September 2nd 2014


126) Tumorigenic Role of TAZ in NSCLC (Clinical Cancer Research) Tuesday September 2nd 2014


127) TP53 Mutations in Advanced NSCLC (Clinical Cancer Research) Tuesday September 2nd 2014


128) Role of miR-409 in Prostate Cancer Bone Metastasis (Clinical Cancer Research) Tuesday September 2nd 2014


129) Androgen and Estrogen Signaling and Stem Cell Markers in Prostate Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


130) Deep Sequencing of Plasma DNA for Tumor Mutation Diagnosis (Clinical Cancer Research) Tuesday September 2nd 2014


131) Gastric Cancer Methylome and Metastasis Biomarkers (Clinical Cancer Research) Tuesday September 2nd 2014


132) LSD1 Inhibitor Blocks Oncogenic EWS/ETS Function (Clinical Cancer Research) Tuesday September 2nd 2014


133) SAR650984: A Novel Antibody for CD38+ Malignancies (Clinical Cancer Research) Tuesday September 2nd 2014


134) Multiple RTKs Confer Lapatinib Unresponsiveness in HER2+ GC (Clinical Cancer Research) Tuesday September 2nd 2014


135) Ang1 and Tie2 Are Predictive Biomarkers for Bevacizumab (Clinical Cancer Research) Tuesday September 2nd 2014


136) MRD Detection by Sequencing in B-ALL (Clinical Cancer Research) Tuesday September 2nd 2014


137) Glutamate Predicts Survival in Medulloblastoma (Clinical Cancer Research) Tuesday September 2nd 2014


138) Determinants of In Vivo ABT-263 Response (Clinical Cancer Research) Tuesday September 2nd 2014


139) Fc{gamma}RIIa and Fc{gamma}RIIIa Polymorphisms and Cetuximab (Clinical Cancer Research) Tuesday September 2nd 2014


140) The KRAS-Variant Predicts Cetuximab Response in Colon Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


141) Biomarkers for Onartuzumab + Erlotinib Therapy in NSCLC (Clinical Cancer Research) Tuesday September 2nd 2014


142) EGFR Expression and Cetuximab Activity in Xenograft Models of NSCLC (Clinical Cancer Research) Tuesday September 2nd 2014


143) Phase I of Inecalcitol with Docetaxel in mCRPC Patients (Clinical Cancer Research) Tuesday September 2nd 2014


144) p53MVA Therapy for Gastrointestinal Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


145) Dabrafenib Dose Selection, Pharmacokinetics, and Pharmacodynamics (Clinical Cancer Research) Tuesday September 2nd 2014


146) ETS Gene Fusions in Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


147) FDA Approval Summary for T-DM1 for HER2+ MBC (Clinical Cancer Research) Tuesday September 2nd 2014


148) Molecular Markers for Personalized Medicine (Clinical Cancer Research) Tuesday September 2nd 2014


149) Rapid Co-development of Drugs and Biomarkers: Is a Single Companion Diagnostic Optimal? (Clinical Cancer Research) Tuesday September 2nd 2014


150) TP53 Mutations and Lung Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


151) Correction: Bim Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia (Clinical Cancer Research) Thursday August 14th 2014


152) Correction: A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer (Clinical Cancer Research) Thursday August 14th 2014


153) Correction: Interleukin-7 Mediates Selective Expansion of Tumor-Redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-Cell Inhibition (Clinical Cancer Research) Thursday August 14th 2014


154) PBX1 Promotes Differentiation in Neuroblastoma (Clinical Cancer Research) Thursday August 14th 2014


155) IL4+ and IL17+ Melan-A-Reactive T Cells in Melanoma (Clinical Cancer Research) Thursday August 14th 2014


156) Combined GNAS and KRAS Testing (Clinical Cancer Research) Thursday August 14th 2014


157) Regulation of Pancreatic Cancer Metabolism by KLF4 (Clinical Cancer Research) Thursday August 14th 2014


158) GCC Lymph Node Ratio and Colon Cancer Recurrence (Clinical Cancer Research) Thursday August 14th 2014


159) Aberrant Methylation of Enhancers in Renal Cell Cancer (Clinical Cancer Research) Thursday August 14th 2014


160) Skin Barrier Dysfunction in CTCL (Clinical Cancer Research) Thursday August 14th 2014


161) Activated Stellate Cells Promote Perineural Invasion (Clinical Cancer Research) Thursday August 14th 2014


162) Resistance to Endocrine Treatment in Luminal Breast Cancer Xenografts (Clinical Cancer Research) Thursday August 14th 2014


163) Selective Targeting of Tumor Cells by DPP-23 (Clinical Cancer Research) Thursday August 14th 2014


164) O3/O2-Pneumoperitoneum-Induced Tumoricidal Immunity (Clinical Cancer Research) Thursday August 14th 2014


165) Functional Kinomics Identifies Therapeutic Targets in HNSCC (Clinical Cancer Research) Thursday August 14th 2014


166) Solid Tumor Induction of CAR T-cell Hypofunction (Clinical Cancer Research) Thursday August 14th 2014


167) MEK Inhibitor RO4987655 in Patients with Solid Tumors (Clinical Cancer Research) Thursday August 14th 2014


168) Rilotumumab, Ganitumab, and Panitumumab in Treatment of mCRC (Clinical Cancer Research) Thursday August 14th 2014


169) Multiple WT1 Peptide-Pulsed Dendritic Cell Vaccines (Clinical Cancer Research) Thursday August 14th 2014


170) Single-Agent Orteronel in Castration-Resistant nmCRPC (Clinical Cancer Research) Thursday August 14th 2014


171) Recommendations for Design of Phase I Combination Trials (Clinical Cancer Research) Thursday August 14th 2014


172) Drug Development for Metastatic Progression in Osteosarcoma (Clinical Cancer Research) Thursday August 14th 2014


173) MEK Inhibitors in KRAS-Mutant Cancers (Clinical Cancer Research) Thursday August 14th 2014


174) NRAS Mutations in Melanoma and AML (Clinical Cancer Research) Thursday August 14th 2014


175) Historical Controls for Advanced Pancreatic Cancer Trials (Clinical Cancer Research) Thursday August 14th 2014


176) CHK It Out! (Clinical Cancer Research) Thursday August 14th 2014


177) Correction: hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications (Clinical Cancer Research) Friday August 1st 2014


178) Hepatic Uptake Transporters and Docetaxel Disposition in Mice--Letter (Clinical Cancer Research) Friday August 1st 2014


179) ALDH1A3 in Non-Small Cell Lung Cancer Stem Cells (Clinical Cancer Research) Friday August 1st 2014


180) microRNA Expression in CLL (Clinical Cancer Research) Friday August 1st 2014


181) Next-Generation Sequencing of Translocation RCC (Clinical Cancer Research) Friday August 1st 2014


182) An Unconventional Oncogenic Signal of EGF (Clinical Cancer Research) Friday August 1st 2014


183) FGFR1/3 Tyrosine Kinase Fusions in Non-Small Cell Lung Cancer (Clinical Cancer Research) Friday August 1st 2014


184) Rescue of NK Cells by Blocking the Induction of MDSCs (Clinical Cancer Research) Friday August 1st 2014


185) CtBP1 and High-Fat Diet Regulate Prostate Cancer Growth (Clinical Cancer Research) Friday August 1st 2014


186) Galeterone Actions as AR Antagonist (Clinical Cancer Research) Friday August 1st 2014


187) Phosphoproteomics of EGFR-TKI Resistance (Clinical Cancer Research) Friday August 1st 2014


188) Synergistic PI3K2 and EGFR Inhibitors for PDACA (Clinical Cancer Research) Friday August 1st 2014


189) Fc-Enhanced TCR-like Antibody against WT1 Peptide/HLA-A2 (Clinical Cancer Research) Friday August 1st 2014


190) Cisplatin Nephrotoxicity Is Dependent on OCT2 and p53 (Clinical Cancer Research) Friday August 1st 2014


191) NADPH Oxidase Inhibitors and BCR-ABL Inhibitors Synergize (Clinical Cancer Research) Friday August 1st 2014


192) BCMab1 Has Antitumor Activity to Bladder Cancer (Clinical Cancer Research) Friday August 1st 2014


193) CS1-Specific CAR T Cells for Myeloma Immunotherapy (Clinical Cancer Research) Friday August 1st 2014


194) Hedgehog Signaling in CD44(+) Gastric Cancer Cells (Clinical Cancer Research) Friday August 1st 2014


195) Transcriptional Response to Fulvestrant and Anastrozole (Clinical Cancer Research) Friday August 1st 2014


196) Biomarkers of Bone Remodeling to Tailor Bisphosphonates (Clinical Cancer Research) Friday August 1st 2014


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

10 Years Ago And Now: Qichun Zhang

The Odd Oxygen

Chalcopyrite

Third Point, Dow Come To Terms

11/21/14 PHD comic: 'Research I Problems'

Synthetic Self-Assembling Nanococoons Mimic Natural Viruses

Daily Pump Trap: 11/20/14 edition

Arrays Aid Scale-Up Of Drug-Candidate Syntheses

Distillations Podcast: Babies on Demand: Reproduction in a Technological Age

Virtual Covalent Screening

Amgen Claims It All

Eye Test Might One Day Diagnose Alzheimer’s Before Symptoms Appear

Tufts Study Finds Big Rise 
In Cost Of Drug Development


House Of Representatives Passes Bills Targeting Environmental Protection Agency

Twisted By Design


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()